Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document explains the genetic causes and characteristics of inherited hair disorders.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Vitamin A affects hair loss and immune response in alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.